OASIS Mailing List ArchivesView the OASIS mailing list archive below
or browse/search using MarkMail.

 


Help: OASIS Mailing Lists Help | MarkMail Help

announce message

[Date Prev] | [Thread Prev] | [Thread Next] | [Date Next] -- [Date Index] | [Thread Index] | [Elist Home]


Subject: [announce] Arbortext Focuses on Life Sciences


Arbortext Focuses on Life Sciences

Provides XML solutions to address pharmaceutical manufacturing,
pharmaceutical package inserts and labels, and regulatory submission
challenges

ANN ARBOR, Mich., September 17, 2002 -- Arbortext, Inc., the only global
provider of XML-based software for multichannel publishing, today
announced its focus on the life sciences industry that includes new
product capabilities and new applications.  This initiative enables
pharmaceutical companies, medical device manufacturers and biotechnology
companies to bring new and revised products to market faster than ever
while complying with complex regulatory requirements, ultimately avoiding
costly penalties such as manufacturing delays, regulatory fines and missed
revenue opportunities.

The new applications are a combination of Arbortext core products, partner
integration and consulting services.  Arbortext’s Epic software provides
the cornerstone for organizations to efficiently create, manage and
publish complex business and technical documents, such as new drug
applications, product information (package inserts, leaflets and labels),
and written documentation of procedures that support the methods,
facilities and controls used in the preparation, processing and packaging
of pharmaceutical and medical products.

Some of the new product capabilities to support this initiative include:
·	Change tracking
·	Enhanced API including support for Active-X
·	Stronger integration with Documentum’s content management system
·	Digital signatures and watermarks

Arbortext provides support for the following applications in life
sciences:
·	Pharmaceutical Manufacturing.  With fines related to manufacturing
process documentation reaching as high as $500 million, drug companies
have a powerful incentive to automate the documentation process to reduce
the risk of incomplete, incorrect or out-of-date information.  Arbortext
consolidates manufacturing documentation into a single source and process
that eliminates redundancy and ensures that all information is consistent
and comprehensive.  Arbortext’s Epic software enables drug manufacturers
to maintain regulatory compliance, prevent costly errors and avoid fines.
Benefits include faster authoring, quicker revision and review cycles,
higher content quality through information reuse, automated formatting and
publishing for multiple purposes and in multiple formats, and penalty
reduction as a result of FDA compliance.
·	Pharmaceutical Package Inserts and Labels.  Package inserts, leaflets
and labels present a particular challenge to the pharmaceutical industry
as they must be modified for each form, dosage and presentation of
medication as well as be delivered in the native language of the consumer.
In Europe, it can take as many as 900 different documents to support a
single drug.  By producing the entire set of documents automatically from
a single source file, Arbortext’s Epic software reduces the resources
needed to create, submit, approve and maintain this product information.
Benefits include both lower costs and faster approvals by focusing review
and approval on the changes since the previous revision.
·	Regulatory Submissions.  Regulatory submissions consist of large amounts
of complex information that must be assembled and submitted to the
regulatory agencies of each country or region where the submitting company
plans to market a product.  For each day the product is delayed going to
market, it can cost the manufacturer $1 million or more.  Arbortext’s Epic
software enables these organizations to meet the requirements of XML-based
submissions because of its capacity to automate the creation, validation
and distribution of large collections of modular data.  Benefits include
better document maintenance by streamlining internal company processes to
support the regulatory approval process.  The end result is getting
products to market faster and increasing revenue.

“Rising drug costs and increased regulatory requirements are just a few of
the challenges that life sciences organizations are facing,” said Tom
DiCorcia, Industry Marketing Director at Arbortext.  “Being first to
market with new drugs, avoiding manufacturing fines from the FDA, and
speeding up regulatory submission processes are critical to maintaining
market leadership.  Arbortext’s focus on certain pharmaceutical
applications will provide pharma companies with a way to increase
efficiencies in the manufacturing, regulatory compliance and product
information initiatives, ultimately increasing revenues and shareholder
value.”

“Arbortext has long been a pioneer in XML authoring and publishing
software,” said Ron Schmelzer, Senior Analyst at ZapThink.  “Arbortext has
shown that is able to offer high-quality, focused software to support
every aspect of the drug development lifecycle – from discovery, clinical
trials and regulatory approvals to manufacturing, marketing and medical
affairs.”

Arbortext customers in the life sciences industry include Abbott
Laboratories, American Medical Association, AstraZeneca, Beckman Coulter,
Bristol-Myers Squibb, Canadian Pharmacists Association, GE Medical
Systems, Guidant CPI, GlaxoSmithKline, Kimberly Clark, M&R Care
Guidelines, Medtronic, Merck, MicroMedics, Novant Health, Pfizer,
Pharmacopeia-Europe, Pharmacopeia-United States and Sanofi-Synthelabo.

About Arbortext
Arbortext is the only global provider of XML-based multichannel software
that enables the creation, editing and publishing of information to
multiple media types – Web, print, CD-ROM, wireless – from a single source
of content.  Shipping since 1991, Arbortext’s standards-based software
supports technical publishing, reference publishing and business
publishing applications that enable enterprises to provide more accurate,
cost-efficient, complete, timely, consistent and usable information on all
media. Arbortext’s software is installed at over 300 large multinational
organizations. Current customers include American Express Financial
Services, Audi, Boeing, British Aerospace, Caterpillar, DaimlerChrysler,
Ericsson Telecom, Ford, General Electric, GM, IBM, International Thomson
Publishing, Lucent, Nokia, Nortel Networks, PeopleSoft, Pfizer, Qantas,
Ricoh, Sun Microsystems, United Airlines, Volkswagen, Volvo and West
Group. Arbortext is a founding member and active participant in the XML
Activity of the World Wide Web Consortium (W3C). Headquartered in Ann
Arbor, Michigan, USA, Arbortext has offices around the world.  For more
information please visit http://www.arbortext.com.
# # #

Contact: 	Beth Ambaruch, APR 			Daylan Burlison
	  	Arbortext, Inc.				Phase Two Strategies
	  	+1 734.327.6014				+1 212.530.7547
	 	bea@arbortext.com				dburlison@p2pr.com



[Date Prev] | [Thread Prev] | [Thread Next] | [Date Next] -- [Date Index] | [Thread Index] | [Elist Home]


Powered by eList eXpress LLC